Drugs

Endothelin Receptor Antagonists in Heart Failure: Current Status and Future Directions
pp. 1029-1040(12)
Authors: Ertl G.; Bauersachs J.

Reversal of Chronic Obstructive Pulmonary Disease-Associated Weight Loss: Are There Pharmacological Treatment Options?
pp. 1041-1052(12)
Authors: Berry J.K.; Baum C.

Management of Hyperlipidaemia Associated with Heart Transplantation
pp. 1053-1068(16)
Author: Wenke K.

Maintenance of Remission in Crohn’s Disease: Current and Emerging Therapeutic Options
pp. 1069-1089(21)
Authors: Brookes M.J.; Green J.R.B.

QT Prolongation with Antimicrobial Agents: Understanding the Significance
pp. 1091-1124(34)
Author: Owens Jr R.C.

Palonosetron
pp. 1125-1132(8)
Authors: Siddiqui M.A.A.; Scott L.J.

Palonosetron: A Viewpoint by Roberto M. Labianca
pp. 1133-1134(2)
Author: Labianca R.M.

Palonosetron: A Viewpoint by Giuseppe Tonini
pp. 1133-1134(2)
Author: Tonini G.

Fixed-Dose Combination Enalapril/Nitrendipine: A Review of its Use in Mild-to-Moderate Hypertension
pp. 1135-1148(14)
Authors: Siddiqui M.A.A.; Plosker G.L.